Current Trends In Development Of Egfr Inhibitors As A Promising Anticancer Agents: Sar And Synthetic Studies From (2010-2020)
Sign Up to like & getrecommendations! Published in 2023 at "Current Organic Chemistry"
DOI: 10.2174/1385272827666230220105034
Abstract: The EGFR (Epidermal Growth Factor Receptor) regulates cell proliferation, survival, and differentiation. The EGFR is a cell surface receptor that belongs to the ErbB tyrosine kinase family. One of the most important targets for cancer… read more here.
Keywords: current trends; egfr inhibitors; 2010 2020; trends development ... See more keywords